An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA to weigh easing limits on unproven peptides Navigating Updated FDA IND Safety Reporting Guidance WCG The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law